ARTICLE | Company News
Abbott pharmaceuticals news
October 22, 2012 7:00 AM UTC
On its 3Q12 earnings call, Abbott said it expects its AbbVie pharmaceutical spinout to record 2013 sales of more than $18 billion. R&D spending is expected to be about $2.5 billion, or 14% of sales. A...